The Business Year Portugal 2023 features an interview with Miguel Garcia, CEO of LxBio, and an article introducing the Bio-Hub Agenda, led by LxBio.

Azbil Telstar will lead the engineering projects for LxBio's new biopharmaceutical production unit.

Technophage team will be in Copenhagen with the team from Israel, presenting the results from Phase I/IIa and compassionate use of TP-102.

LxBio Pharmaceuticals, SA announces a new phase of the Mobilizing Agenda Bio-Hub

Bio-hub Agenda receives 13% advance

TechnoPhage announces completion of innovative clinical trial with bacteriophage cocktail indicated for the treatment of diabetic foot infections (TP-102)